Target intelligence / Profile preview

c-MYC promoter G-quadruplex DNA (c-MYC G4) (c-MYC G4)

Target
c-MYC G4
Molecular classification
Nucleic acid, Non-canonical DNA structure, Transcription regulatory element
01

Overview

The c-MYC G-quadruplex DNA is a non-canonical secondary structure formed within the Nuclease Hypersensitive Element III1 (NHE III1) of the c-MYC oncogene promoter (Siddiqui-Jain et al., 2002, PNAS). This structure acts as a molecular switch that regulates the transcription of c-MYC, a master regulator of cell growth, proliferation, and metabolism (Brooks et al., 2010, Genes & Cancer). In many cancers, c-MYC is overexpressed, driving uncontrolled cellular division and survival (Balasubramanian et al., 2011, Nature Reviews Drug Discovery). Small molecules designed to stabilize this G-quadruplex structure effectively lock the promoter in an inactive state, preventing the assembly of the transcriptional machinery and reducing oncogene expression (Yang and Hurley, 2006, Molecular Cancer Therapeutics). Some advanced therapeutic strategies involve dual-targeting ligands that bind both the G-quadruplex and adjacent A-T rich minor groove regions to enhance binding affinity and selectivity over other genomic G-quadruplexes (Ou et al., 2008, Journal of Medicinal Chemistry). Despite its potential, targeting this region remains challenging due to the structural similarity between different G-quadruplexes across the genome and the need for high specificity to avoid systemic toxicity.

Other names
NHE III1 G-quadruplexMYC G4 DNAc-MYC Pu27 G-quadruplexc-MYC promoter nuclease hypersensitive element III1c-MYC G-quadruplex DNA / A-T rich minor groove regions
02

Mechanism of action

Stabilization of the G-quadruplex structure within the c-MYC promoter region to sterically inhibit transcription factor binding and RNA polymerase recruitment, leading to the downregulation of c-MYC oncogene expression (Siddiqui-Jain et al., 2002; Yang and Hurley, 2006).

03

Biological functions

Transcription regulationGene expression controlCell cycle regulation
04

Disease associations

CancerBurkitt lymphomaBreast cancerProstate cancerLeukemia
05

Safety considerations

Off-target binding to other genomic G-quadruplexesPotential telomere dysfunctionGenomic instabilityPoor drug-like properties of G4 ligands
06

Interacting drugs

TMPyP4

7 more in the full profile.

07

Biomarkers

c-MYC protein expressionc-MYC mRNA levelsG-quadruplex formation (BG4 antibody)

Beyond the preview

Go deeper on c-MYC promoter G-quadruplex DNA (c-MYC G4) (c-MYC G4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on c-MYC promoter G-quadruplex DNA (c-MYC G4) (c-MYC G4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call